Predicting Abrocitinib Efficacy at Week 12 Based on Clinical Response at Week 4: A Post Hoc Analysis of Four Randomized Studies in Moderate-to-Severe Atopic Dermatitis.
Dermatology and Therapy（2024）
关键词
Abrocitinib,Atopic dermatitis,Janus kinase inhibitors,Flexible dose,Platelets,Predictors of response,Clinical trials
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要